Future Thinking France launches pharma healthcare division

The new division will be known as Future Thinking Pharma and will be headed by Béatrice Chemla (pictured), previously founder and CEO of Listening Pharma.

The company said its 20% growth in the past 12 months has enabled it to diversify into the pharmaceutical and healthcare sector, with the intention to further expand its blue chip client roster across Europe.

Stéphane Marder, CEO at Future Thinking France, said: “Strengthening and formalising our healthcare expertise will enable us to offer the pharmaceutical industry unique and innovative tools developed by Quantum Lab, our in-house think tank of new ideas, approaches and products.”